Covered recipient · General Payments record
KARTHY THIAGARAJAN
Allopathic & Osteopathic Physicians Family Medicine Sleep Medicine
General Payments · PY2018–2024
$372.96
- Reported across 22 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $273.82 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $141.26 | 10 |
| Novo Nordisk AS | $36.93 | 2 |
| GlaxoSmithKline, LLC. | $32.90 | 2 |
| Acerta Pharma LLC | $27.42 | 1 |
| Lundbeck LLC | $19.98 | 1 |
| Nevro Corp. | $15.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $27.42 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104531598 | CMS |
| GlaxoSmithKline, LLC. | $13.83 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116725422 | CMS |
| GlaxoSmithKline, LLC. | $19.07 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116231313 | CMS |
| Lilly USA, LLC | $12.98 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135096002 | CMS |
| Lilly USA, LLC | $23.99 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135097950 | CMS |
| Lilly USA, LLC | $12.60 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135119415 | CMS |
| Lilly USA, LLC | $12.98 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135097948 | CMS |
| Lilly USA, LLC | $21.21 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135121377 | CMS |
| Lilly USA, LLC | $12.07 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135096004 | CMS |
| Lilly USA, LLC | $12.04 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135121875 | CMS |
| Lilly USA, LLC | $12.48 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135076401 | CMS |
| Lilly USA, LLC | $9.32 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135121873 | CMS |
| Lilly USA, LLC | $11.59 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135096006 | CMS |
| Lundbeck LLC | $19.98 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145975093 | CMS |
| Nevro Corp. | $15.33 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130772910 | CMS |
| Novo Nordisk Inc | $17.61 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097243261 | CMS |
| Novo Nordisk Inc | $19.32 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097677213 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.